Measurement of Plasma and Intracellular Concentrations of Raltegravir
Status:
Completed
Trial end date:
2011-06-30
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to analyze and compare plasma and intracellular
concentrations of Raltegravir (RAL) in blood plasma and in peripheral blood mononuclear
cells, using high performance liquid chromatography (HPLC).